HPR28 Last Resort for Reimbursement of New Drugs in Germany: When the Arbitration Office Must Decide
| Autor: | Glüsen, M, Rehkopf, J, Martyniszyn-Eiben, A, Kielhorn-Schönermark, H, Schönermark, M |
|---|---|
| Zdroj: | In Value in Health December 2022 25(12) Supplement:S237-S237 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect